Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastases 2 Recurrence 1 Liver Neoplasms 1 Breast Neoplasms 1

Interventions

Sorafenib 23 Bevacizumab 11 Radiosurgery 6 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Erlotinib Hydrochloride 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Nivolumab 3 Leucovorin 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × Electrochemotherapy × Clear all

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡